Oxygenta Pharma: Audited Financial Results for Year Ended 31.03.2026

Oxygenta Pharmaceutical Ltd's board approved the audited financial results for the quarter and year ended March 31, 2026. The board also approved the appointment of Mr. Amireddy Venkatesu Reddy as an Additional Director (Executive category) and Mr. Janardhana Reddy Yeddula as an Additional Director (Independent Category), both effective from May 23, 2026, subject to shareholder approval. Additionally, M/s. Suryachandra & Associates were appointed as Internal Auditors for FY 2026-27, and M/s. Aakanksha Dubey & Co. will serve as Scrutinizer for the e-voting process at the upcoming Annual General Meeting.